HHS (Health and Human Services) panel gets to work on regulatory reform options
This article was originally published in Clinica
Executive Summary
The US Prescription Drug User Fee Act (PDUFA) was one of three regulatory programmes cited as "existing best practices" last week at an organisational meeting of a new advisory panel set up to examine how to ease regulatory burdens within the Department of Health and Human Services (HHS).